Emcure Pharmaceuticals Limited (BOM:544210)
2,336.05
-9.85 (-0.42%)
At close: Nov 20, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 443.43 billion as of November 20, 2026. Its market cap has increased by 70.73% in one year.
Market Cap
443.43B
Enterprise Value
459.53B
Revenue
102.34B
Global Rank
n/a
Country Rank
n/a
PE Ratio
40.53
ChartMarket Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 443.43B, an increase of 72.58%. That is a compound annual growth rate of 25.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 443.43B | 71.43% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aurobindo Pharma | 1.05T |
| Glenmark Pharmaceuticals | 749.44B |
| Alkem Laboratories | 618.39B |
| Gland Pharma | 550.51B |
| Ipca Laboratories | 466.77B |
| Emcure Pharmaceuticals | 444.50B |
| Ajanta Pharma | 414.14B |
| Wockhardt | 354.07B |